Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro KwikPen delivers a single weekly dose of tirzepatide under the skin of your abdomen, thigh or upper arm. Each pre-filled pen contains four doses; you turn the dose selector to the correct setting, pinch the skin, press the pen firmly against it and hold for around ten seconds until the click confirms injection. Because Mounjaro is a prescription-only medicine, the full technique for using the Mounjaro pen should always be confirmed with the prescriber who approves your treatment — and the Patient Information Leaflet supplied with every pen is the definitive reference for individual steps. The NHS's tirzepatide guidance sets out what good injection practice looks like and what to do if something feels wrong.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC and Patient Information Leaflet (the authoritative source for any injection you use) ask you to check four things before every dose: that the pen's dose window shows the right number, that the liquid looks clear and colourless (not cloudy or containing particles), that the pen hasn't been frozen, and that the expiry date hasn't passed. Using an expired Mounjaro pen is something our prescribers are asked about regularly; the short answer is that you should not inject it and should contact your clinical team for guidance.
The NHS's clinical guidance on tirzepatide also notes that Mounjaro should be taken on roughly the same day each week. If you want to move your injection day, you can shift it by a day or two, but only so the doses are never closer together than four days. Your prescriber is the right person to walk you through that, not a forum post.
One misconception worth clearing up gently: many people assume the injections become painful over time as the skin toughens. In practice, the needles used with the KwikPen are very fine, and rotating sites (moving a few centimetres from the last spot) is the main way to keep injections comfortable. Injection-site reactions reported in clinical trials were generally mild.
Remove the pen from the fridge around 30 minutes before you plan to inject; cold liquid can cause more discomfort. Wash your hands. Clean the intended injection site with an alcohol swab and let it air-dry (sterile alcohol swabs are a practical addition to your routine if you don't already have them at home) before you begin.
Attach a fresh needle. The dose dial should be set to the prescribed dose level; never adjust it yourself without your prescriber's instruction. Pinch a fold of skin gently with your non-dominant hand. Press the pen flat against the skin (it does not need to be at a specific angle, the pen is designed to self-direct) then press the injection button and count slowly. Our guide to how Mounjaro injections work in practice covers what a slow count feels like and walks you through each step in detail. A second click signals the injection is complete. Release the button, then lift the pen away.
Dispose of the used needle immediately in a designated sharps container. A 1-litre sharps bin keeps used needles safe until your local council collection. Recap nothing; resheathing loose needles is a common cause of accidental needlestick injuries.
The SURMOUNT-1 trial (the largest published study of tirzepatide for weight management, involving 2,539 adults) showed that average body-weight reduction at 72 weeks reached around 20–21% at the 15 mg dose, with results building across the titration period rather than arriving immediately. The published SURMOUNT-1 paper in the New England Journal of Medicine makes clear that the early weeks of treatment, when many people are still on 2.5 mg or 5 mg, are primarily about tolerability, your system adjusting to the medicine's effects on gastric emptying and appetite signalling.
NICE's appraisal of tirzepatide (TA1026) reflects this: the recommended approach is slow escalation under prescriber oversight, with review of response before each step up. That is why the Mounjaro injection is always supplied as a prescription medicine rather than sold freely, the titration schedule is a clinical decision, not a fixed rule that applies identically to every patient. If you feel ready to increase your dose, that's a conversation to have with your prescriber, not a dial to turn on your own.
For an overview of what Mounjaro costs privately in the UK, that page covers what the price typically includes and what to look for when comparing providers. The short version: a legitimate price includes clinical assessment and a prescription, not just the pen.
The most commonly reported side effects during Mounjaro treatment are gastrointestinal: nausea, diarrhoea, constipation, indigestion and burping. The NHS tirzepatide page lists these alongside the less common reactions worth knowing about. They tend to peak in the first few days after an injection or a dose increase, and for many people settle within a week or two as the body adapts.
Injection-site redness or mild discomfort is also reported and usually resolves quickly. Rotating sites (abdomen one week, thigh the next, upper arm after that, and moving within each area each time) is the practical measure that reduces this most reliably, and our full guidance on how to take your Mounjaro injection covers this and other technique details in one place.
Seek urgent medical attention for severe abdominal pain that spreads to the back, with or without vomiting; this can be a sign of pancreatitis, which the MHRA highlighted as a known but infrequent risk in its January 2026 Drug Safety Update for GLP-1 medicines. Signs of a serious allergic reaction (throat swelling, difficulty breathing, a spreading rash) also require immediate help. You can report any suspected side effects through the MHRA Yellow Card scheme.
If you have questions about your injection technique or how you're feeling on treatment, our prescribers offer priority aftercare seven days a week. You can also start a free consultation with our clinical team if you haven't yet begun treatment and want to understand whether Mounjaro is the right option for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.